Back
GRI Bio, Inc. GRI · Insights
GRI Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and c... Price1.71
Market Cap3.74 M
Float2.19 M
CountryUS
SectorHealthcare
ExchangeNASDAQ
OverviewFilingsInsightsDilutionNewsTranscriptsInsights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro